Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue

Issues

Homocysteine and heart failure: a review of investigations from the Framingham Heart Study

Johan Sundström1 / Ramachandran S. Vasan2

1.

2.

Corresponding author: Ramachandran S. Vasan, MD, The Framingham Study, 73 Mt. Wayte Ave, Framingham, MA 01702-5803, USA Phone: +1-508-935-3450, Fax: +1-508-626-1262,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 43, Issue 10, Pages 987–992, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2005.173, September 2005

Publication History

Published Online:
2005-09-30

Abstract

High plasma homocysteine levels are associated with a moderately increased risk of cardiovascular disease, particularly of atherosclerotic events. We review the association of plasma homocysteine with heart failure, with a specific focus on a series of previously published investigations from the community-based Framingham Heart Study that evaluated the relations of plasma homocysteine levels with overt heart failure, and with its key antecedents, echocardiographic left ventricular (LV) mass and hypertension. In the Framingham sample, higher plasma homocysteine levels were associated with increased risk of new-onset heart failure in both men and women, with a more continuous and graded relation being observed in women. A positive relation between homocysteine and LV mass was observed in women, but not in men; this may underlie the stronger relations of homocysteine to heart failure risk in women. Plasma homocysteine was not associated with hypertension incidence prospectively in either sex. The relations of increased homocysteine to heart failure (in both sexes) and to greater LV mass (in women) noted in the Framingham sample should be confirmed in other community-based samples. Secondary analyses of heart failure outcomes in ongoing randomized clinical trials may provide insights into whether lowering of plasma homocysteine levels is associated with a reduction in LV mass and/or a reduction of heart failure risk.

Keywords: epidemiology; heart failure; homocysteine; left ventricular hypertrophy

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Satish Kenchaiah and Ramachandran S. Vasan
Cardiovascular Drugs and Therapy, 2015
[2]
Yvonne Lee Yin Leng, Yuling Zhou, Honghong Ke, Herbert Jelinek, Joel McCabe, Hassan Assareh, and Craig S. McLachlan
Medicine, 2015, Volume 94, Number 27, Page e1080
[3]
Huan Zheng, Ye Li, Nanzi Xie, Huifeng Xu, Junling Huang, and Ming Luo
Clinical and Experimental Hypertension, 2014, Volume 36, Number 3, Page 181
[4]
C. de jaeger, N. Fraoucene, E. Voronska, and P. Cherin
Médecine & Longévité, 2010, Volume 2, Number 2, Page 73
[5]
Bradley A. Maron and Joseph Loscalzo
Clinics in Laboratory Medicine, 2006, Volume 26, Number 3, Page 591
[6]
Jessica A. Sipkens, Paul A. J. Krijnen, Nynke E. Hahn, Melissa Wassink, Christof Meischl, Desirée E. C. Smith, René J. P. Musters, Coen D. A. Stehouwer, Jan A. Rauwerda, Victor W. M. van Hinsbergh, and Hans W. M. Niessen
Molecular and Cellular Biochemistry, 2011, Volume 358, Number 1-2, Page 229
[7]
Jessica A. Sipkens, Nynke E. Hahn, Geerten P. van Nieuw-Amerongen, Coen D.A. Stehouwer, Jan A. Rauwerda, Victor W.M. van Hinsbergh, Hans W.M. Niessen, and Paul A.J. Krijnen
Cellular Physiology and Biochemistry, 2011, Volume 28, Number 1, Page 53
[8]
Pierre Gibelin, Stephanie Serre, Mirande Candito, Bakhouche Houcher, Frederic Berthier, and Marcel Baudouy
Clinical Chemical Laboratory Medicine, 2006, Volume 44, Number 7
[9]
Jessica A. Sipkens, Paul A. J. Krijnen, Christof Meischl, Saskia A. G. M. Cillessen, Yvo M. Smulders, Desirée E. C. Smith, Cindy P. E. Giroth, Marieke D. Spreeuwenberg, René J. P. Musters, Alice Muller, Cornelis Jakobs, Dirk Roos, Coen D. A. Stehouwer, Jan A. Rauwerda, Victor W. M. van Hinsbergh, and Hans W. M. Niessen
Apoptosis, 2007, Volume 12, Number 8, Page 1407

Comments (0)

Please log in or register to comment.